(Q43614611)

English

Cellulose acetate phthalate (CAP): an 'inactive' pharmaceutical excipient with antiviral activity in the mouse model of genital herpesvirus infection

scientific article published in November 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Cellulose acetate phthalate (CAP): an 'inactive' pharmaceutical excipient with antiviral activity in the mouse model of genital herpesvirus infection (English)

1 reference

Europe PubMed Central

25 November 2017

1 reference

based on heuristic

inferred from title

author name string

T Gyotoku

1

1 reference

Europe PubMed Central

25 November 2017

L Aurelian

2

1 reference

Europe PubMed Central

25 November 2017

A R Neurath

3

1 reference

Europe PubMed Central

25 November 2017

publication date

1 November 1999

1 reference

Europe PubMed Central

25 November 2017

Antiviral Chemistry & Chemotherapy

1 reference

Europe PubMed Central

25 November 2017

10

1 reference

Europe PubMed Central

25 November 2017

6

1 reference

Europe PubMed Central

25 November 2017

327-332

1 reference

Europe PubMed Central

25 November 2017

Herpes simplex virus type 2--a persistent problem

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Herpes simplex virus-mediated activation of human immunodeficiency virus is inhibited by oligonucleoside methylphosphonates that target immediate-early mRNAs 1 and 3.

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Herpes simplex virus type 2 in the United States, 1976 to 1994.

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in-vitro

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Mucosal disruption due to use of a widely-distributed commercial vaginal product: potential to facilitate HIV transmission.

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Interpolymer complexes. Properties and characterization

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Reducing the risk of Chlamydia trachomatis genital tract infection by evaluating the prophylactic potential of vaginally applied chemicals

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Differences in Neurovirulence among Isolates of Herpes Simplex Virus Types 1 and 2 in Mice using Four Routes of Infection

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Safety Study of Nonoxynol-9 as a Vaginal Microbicide: Evidence of Adverse Effects

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Effect of Immunization on Acute and Latent Infections of Vaginouterine Tissue with Herpes Simplex Virus Types 1 and 2

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Tests of vaginal microbicides in the mouse genital herpes model

1 reference

https://api.crossref.org/works/10.1177%2F095632029901000604

21 January 2018

Identifiers

10.1177/095632029901000604

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43614611&oldid=2101904630"